Benns, H. J.
Storch, M.
Falco, J. A.
Fisher, F. R.
Tamaki, F.
Alves, E.
Wincott, C. J.
Milne, R.
Wiedemar, N.
Craven, G.
BaragaƱa, B.
Wyllie, S.
Baum, J.
Baldwin, G. S.
Weerapana, E.
Tate, E. W.
Child, M. A. http://orcid.org/0000-0002-1565-5638
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/M011178/1, BB/M011178/1, BB/M011178/1)
Medicines for Malaria Venture (RD-09-0043, RD-09-0043, RD-09-0043, RD-09-0043)
Wellcome Trust (203134/Z/16/Z, 203134/Z/16/Z, 203134/Z/16/Z, 203134/Z/16/Z, 203134/Z/16/Z, 100993/Z/13/Z, 202553/Z/16/Z)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM134964)
Article History
Received: 10 June 2022
Accepted: 9 September 2022
First Online: 20 October 2022
Competing interests
: The authors declare no conflicts or competing interests.